RecruitingNCT05015452

The Leipzig TAVI Registry

An Observational Follow-up Assessment of Transcatheter Aortic Valve Implantation in Leipzig


Sponsor

Helios Health Institute GmbH

Enrollment

20,000 participants

Start Date

Mar 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All patients treated with TAVI

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter Aortic Valve Implantation

Interventional replacement of the aortic valve


Locations(1)

Herzzentrum Leipzig

Leipzig, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05015452


Related Trials